Shattuck Labs, Inc.
Heterodimeric proteins for modulating gamma delta T cells

Last updated:

Abstract:

The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.

Status:
Grant
Type:

Utility

Filling date:

13 Jan 2020

Issue date:

24 Aug 2021